Membership Directory

Hepregen Corporation

Category: Research Products and Instrumentation
Phone: 781-391-0205
Fax: 781-391-0315

Hepregen Corporation, a privately held company based in Medford, MA, has developed a proprietary ‘micro-liver’ platform based on microfabrication and tissue engineering technologies. Hepatocytes in this platform maintain high levels of function for weeks, as compared to days in conventional systems. Hepregen’s platform may generate higher content data that delivers efficiencies and improved economics in preclinical testing. The initial application of this novel tool will initially be used for ADME/Tox screening. Its utility in drug development extends well beyond ADME/Tox including applications in drug discovery, disease modeling, in silico models, and toxicogenomics. The Company has an exclusive license to a portfolio of patents based on scientific work conducted by MIT Professor Sangeeta Bhatia, a biomedical engineer and physician scientist. Dr. Bhatia is a pioneer in applying micro- and nanotechnology to the problems of tissue repair and regeneration. The company was founded in 2007 and closed its Series A financing with Battelle Ventures in 2008.

Back to list

Recent Jobs